Development of high concentration protein biopharmaceuticals: the use of platform approaches in formulation development

NW Warne - European journal of pharmaceutics and …, 2011 - Elsevier
The development of highly concentrated solutions of monoclonal antibodies has become
increasingly popular in biotechnology firms as doses increase, and the demand for sub …
被引用次数：161 相关文章

[引用][C] Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development

NW WARNE - European journal of pharmaceutics and …, 2011 - pascal-francis.inist.fr
Development of high concentration protein biopharmaceuticals: The use of platform
approaches in formulation development CNRS Inist Pascal-Francis CNRS Pascal and …

Development of high concentration protein biopharmaceuticals: the use of platform approaches in formulation development.

NW Warne - European Journal of Pharmaceutics and …, 2011 - europepmc.org
The development of highly concentrated solutions of monoclonal antibodies has become
increasingly popular in biotechnology firms as doses increase, and the demand for sub …

Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development

NW Warne - European Journal of Pharmaceutics and …, 2011 - infona.pl
The development of highly concentrated solutions of monoclonal antibodies has become
increasingly popular in biotechnology firms as doses increase, and the demand for sub …
[PDF] ucsc.edu

[PDF][PDF] Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development

NW Warne - European Journal of Pharmaceutics and …, 2011 - people.ucsc.edu
abstract The development of highly concentrated solutions of monoclonal antibodies has
become increasingly popular in biotechnology firms as doses increase, and the demand for …

Development of high concentration protein biopharmaceuticals: the use of platform approaches in formulation development

NW Warne - European journal of pharmaceutics and …, 2011 - pubmed.ncbi.nlm.nih.gov
The development of highly concentrated solutions of monoclonal antibodies has become
increasingly popular in biotechnology firms as doses increase, and the demand for sub …

[引用][C] Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development

NW Warne - European Journal of Pharmaceutics and …, 2011 - cir.nii.ac.jp
Development of high concentration protein biopharmaceuticals: The use of platform approaches
in formulation development | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

[引用][C] Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development

NW WARNE - European journal of pharmaceutics and …, 2011 - Elsevier